Ironwood Pharmaceuticals (IRWD) SG&A Expense (TTM): 64.55M | YCharts

Ironwood Pharmaceuticals, Inc. (IRWD)

3.58 -0.19 (-5.04%) USD | NASDAQ | Oct 16, 09:54

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2009. Start Trial.

Date	Value
June 30, 2026	64.55M
March 31, 2026	70.03M
December 31, 2025	82.26M
September 30, 2025	96.29M
June 30, 2025	110.50M
March 31, 2025	130.67M
December 31, 2024	144.01M
September 30, 2024	149.35M
June 30, 2024	149.28M
March 31, 2024	164.80M
December 31, 2023	158.31M
September 30, 2023	148.04M
June 30, 2023	140.61M
March 31, 2023	118.25M
December 31, 2022	115.99M
September 30, 2022	116.29M
June 30, 2022	115.41M
March 31, 2022	112.34M
December 31, 2021	111.13M
September 30, 2021	116.43M
June 30, 2021	123.61M
March 31, 2021	131.20M
December 31, 2020	140.00M
September 30, 2020	145.21M
June 30, 2020	151.20M

Date	Value
March 31, 2020	159.80M
December 31, 2019	172.45M
September 30, 2019	183.68M
June 30, 2019	193.30M
March 31, 2019	209.83M
December 31, 2018	222.65M
September 30, 2018	230.18M
June 30, 2018	241.42M
March 31, 2018	239.44M
December 31, 2017	233.12M
September 30, 2017	230.38M
June 30, 2017	213.59M
March 31, 2017	192.72M
December 31, 2016	173.28M
September 30, 2016	149.58M
June 30, 2016	135.03M
March 31, 2016	131.07M
December 31, 2015	125.25M
September 30, 2015	124.32M
June 30, 2015	122.41M
March 31, 2015	118.76M
December 31, 2014	118.33M
September 30, 2014	116.48M
June 30, 2014	118.21M
March 31, 2014	119.78M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

AbbVie, Inc.	14.67B
Xencor, Inc.	65.28M
Viking Therapeutics, Inc.	50.70M
IDEAYA Biosciences, Inc.	77.07M
BioMarin Pharmaceutical, Inc.	1.368B